Cargando…
IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas
The insulin-like growth factor 1 receptor (IGF-1R) governs several signaling pathways for cell proliferation, survival, and anti-apoptosis. Thus, targeting IGF-1R appears as a reasonable rationale for tumor treatment. However, clinical studies showed that inhibition of IGF-1R has very limited effica...
Autores principales: | Wang, Qing, Zhang, Yan, Zhu, Jiang, Zheng, Honggang, Chen, Shuntai, Chen, Li, Yang, Hsin-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447751/ https://www.ncbi.nlm.nih.gov/pubmed/32843616 http://dx.doi.org/10.1038/s41392-020-0204-0 |
Ejemplares similares
-
Platycodin D induces apoptosis through JNK1/AP-1/PUMA pathway in non-small cell lung cancer cells: A new mechanism for an old compound
por: Chen, Shuntai, et al.
Publicado: (2022) -
MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R
por: Ge, Yi-Yuan, et al.
Publicado: (2014) -
A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours
por: Wilky, B A, et al.
Publicado: (2015) -
IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
por: Patel, Hima, et al.
Publicado: (2021) -
Inhibiting IGF1R-mediated Survival Signaling in Head and Neck Cancer with the Peptidomimetic SSTN(IGF1R)
por: Stueven, Noah A., et al.
Publicado: (2023)